Viewing Study NCT04870892



Ignite Creation Date: 2024-05-06 @ 4:06 PM
Last Modification Date: 2024-10-26 @ 2:03 PM
Study NCT ID: NCT04870892
Status: UNKNOWN
Last Update Posted: 2021-05-04
First Post: 2021-04-23

Brief Title: Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock
Sponsor: Bicetre Hospital
Organization: Bicetre Hospital

Study Overview

Official Title: Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock
Status: UNKNOWN
Status Verified Date: 2021-04
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: NOVECAR
Brief Summary: The purpose of this study is to assess the effect of norepinephrine and fluid expansion on capillary refill time during septic shock
Detailed Description: An interventional study compared in septic shock the effect of resuscitation strategy targeting normalization of capillary refill time versus strategy targeting serum lactate level This last highlight a decrease of organ dysfunction at 72 hours with capillary refill time strategy and non-significant trend towards lower 28-day mortality in the capillary refill time strategy group

The strategy guided by the decreasing of capillary refill time allowed the administration of less fluid than that guided by lactate This is an important advantage when the intensive care doctor know that the mortality of patient in septic shock increases with the amount of fluid administered

However the variations of capillary refill time induced by the principal treatment in septic shock norepinephrine and fluid resuscitation during circulatory failure are actually insufficiently described The purpose of this study is to assess the effect of norepinephrine and fluid expansion on capillary refill time during septic shock

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None